Company intelligence / Profile preview

OmegaChem

Ownership: Private
Development stage: Commercial

Overview

OmegaChem specialized in contract research services for chemical drug discovery, including design and synthesis of new molecules with biological activity. The company did not have its own clinical pipeline but supported biopharma clients in preclinical candidate identification and early chemical development.

Modalities: Small moleculeChemical synthesis
Industry: Drug Discovery Services

Partnerships

NuChem Sciences (post-acquisition)Fonds de solidarité FTQInvestissement QuébecBDC Capital

Beyond the preview

Go deeper on OmegaChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OmegaChem.

Explore the full profile